Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. - Vieta,E.; Goikolea,J.M.; Corbella,B.; Benabarre,A.; Reinares,M.; Martinez,G. (J Clin Psychiatry, 2001)